External Funding Opportunities

Funding Opportunity

Deadline

NIH Administrative Supplement for Research on Dietary Supplements  This FOA announces the availability of administrative supplements to support research in which the supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. Parent awards need not be focused on dietary supplements; this FOA may provide support to include dietary supplements within the scope of relevant research projects. Research interests of ODS are not limited to specific health conditions, organ systems or population groups. ODS supports all types of research, including pre-clinical, clinical, behavioral, and epidemiological.

October 15

NIH Notice of Special Interest: Alzheimer’s-focused administrative supplements for NIH grants that are not focused on Alzheimer’s disease

October 16

NIH Ethical, Legal and Social Implications (ELSI) Research  This FOA invites applications that propose to study the ethical, legal and social implications (ELSI) of human genome research.  Applications may propose studies using either single or mixed methods.  Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders. 

 October 19

NIH Fertility Status as a Marker for Overall Health  This FOA focuses on studies evaluating fertility as a marker for overall health, and therefore applications that look at the effects of the disease or disorder on fertility are outside of the scope of this program.

 October 19

NIH Aging, Cancer-Initiating Cells, and Cancer Development (U01)

 October 27

NIH Investigator-Initiated Research on Genetic Counseling Processes and Practices  The purpose of this initiative is to support investigator-initiated research on genetic counseling processes and practices in genomic medicine. Research is needed to optimize the genetic counseling process in the context of limited resources. Applications will assess, innovate, scale, and/or research the implementation of novel genetic counseling practices to address the need for more healthcare professionals trained in genetic counseling; the uneven access to in-person genetic counseling across U.S. health care systems; and the challenges of effective and efficient communication of genomic findings to clinicians, patients, and families.

 October 28

NIH-NCI Visualization Methods and Tools Development for Enhancing Cancer Moonshot Data (R33) 

October 30

NIH Innovative Research in Cancer Nanotechnology (IRCN) (R01) 

November 4

NIH Tobacco Control Policies to Promote Health Equity  This FOA aims to stimulate scientific inquiry focused on innovative state and local level tobacco prevention and control policies. The long-term goal of this FOA is to reduce disparities in tobacco-related cancers, and in doing so, to promote health equity among all populations.

 November 12

NIH Genomic Data Analysis Network: Genomic Data Center (U24) 

November 12

NIH New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01)

November 18

NIH Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01)

February 10, 2021

NIH Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01) 

March 15

NIH Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18)  This FOA invites applications from investigators who strive to expand their research trajectories through the acquisition of new knowledge and skills in the areas of basic psychological processes, sociological processes, and/or biomedical pathways—expertise that is beyond and enhances their current areas of expertise. The program will support career development experiences and a small-scale research project that will provide experienced investigators with the scientific competencies required to conduct independent research projects that more thoroughly investigate interrelationships among behavioral, biological, endocrine, epigenetic, immune, inflammatory, neurological, psychological, and/or social processes. This program requires basic experimental studies with humans.

March 17, 2021

NIH Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards  The overarching goal of this pilot program is to enhance the retention of investigators facing critical life events who are transitioning to the first renewal of their first independent research project grant award or to a second new NIH research project grant award. Retention at the first renewal or continuous NIH research project grant support is crucial for sustaining both the ongoing research NIH has made an investment in and for retaining diversity in the biomedical research workforce. Deadline:  Varies by awarding IC

 Varies

NIH Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers  The purpose of this Notice of Special Interest (NOSI) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals. Research efforts that identify specific contributions of HIV infection and its potential interaction with other pathogens towards the development and pathogenesis of these cancers and provide information on the clinical outcomes of such cancers in the HIV-infected population are sought.  Deadline:  Applies to due dates on or after May 7, 2020 through January 8, 2023

 Varies

Funding Opportunity

Deadline

DOD-CDMRP Rare Cancers Research Program (RCRP) November 30

NSF Biophotonics

On-going

NSF Division of Molecular and Cellular Biosciences: Investigator-initiated research projects (MCB)  

On-going

DOE-JGI CSP New Investigator 

On-going

NSF Big Ideas updates

Varies

DOD-CDMRP Peer Reviewed Cancer Research Program (PRCRP)  The PRCRP is charged by Congress with the mission to investigate cancer risks and knowledge gaps that may be relevant to active duty Service members, their families, other military beneficiaries, and the American public.  Mechanisms include:  Virtual Cancer Center Director Award; Career Development Award – Fellow Option; Career Development Award – Virtual Cancer Center Scholar Option; Idea Award; Impact Award; Behavioral Health Science Award; and Translational Team Science Award. 

Varies

DOD-CDMRP Lung Cancer Research Program (LCRP)

The vision of the FY20 LCRP is to eradicate deaths and suffering from lung cancer to better the health and welfare of military Service members, Veterans, and the American public. As such, the LCRP will support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer. Mechanisms include:  Concept award, Idea development award, and Investigator initiated translational research award. Deadlines:  vary by mechanism

Varies

DOD-CDMRP Breast Cancer Research Program (BCRP)   The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP seeks to accelerate high-impact research with clinical relevance, encourage innovation and stimulate creativity, and facilitate productive collaborations. Mechanisms include: Breakthrough Award Levels 1 and 2; Breakthrough Award Level 3; Breakthrough Award Level 4; Era of Hope Scholar Award; Innovator Award; and Transformative Breast Cancer Consortium Award.

Varies

Damon Runyon Cancer Research Foundation  The Damon Runyon Cancer Research Foundation, we fund high-risk, high-reward cancer research.  The foundation provides a variety of cancer-related funding opportunities. Deadline:  Varies by opportunity

Varies